Ukraine c.bank keeps key rate unchanged at 25% as war rages on

Author of the article: KYIV — Ukraine’s central bank kept its main interest rate unchanged at 25% on Thursday, saying that inflationary pressure remained high and that an extended full-scale war with Russia was the key economic risk. In a statement, the central bank said inflation had been slightly slower than its earlier forecast and…
Ukraine c.bank keeps key rate unchanged at 25% as war rages on

Author of the article:

KYIV — Ukraine’s central bank kept its main interest rate unchanged at 25% on Thursday, saying that inflationary pressure remained high and that an extended full-scale war with Russia was the key economic risk.

In a statement, the central bank said inflation had been slightly slower than its earlier forecast and that inflation would remain under control.

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

It said the central bank was ready to hike the rate if required and to deploy other measures to protect its international reserves and maintain control over inflation.

“Inflationary pressure remains high,” it said.

“Effects of the war, in particular the destruction of production facilities and disruption of logistics, still have a major impact on prices of almost all goods and services in the consumer basket,” it said. (Reporting by Max Hunder and Pavel Polityuk; writing by Tom Balmforth; Editing by Jon Boyle)

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
U.S. FDA approves Revance’s wrinkle treatment
Read More

U.S. FDA approves Revance’s wrinkle treatment

This advertisement has not loaded yet, but your article continues below. Author of the article: Article content Revance Therapeutics said on Thursday it has received the U.S. Food and Drug Administration’s Financial Post Top Stories Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc. By clicking…
Minerva Issues Options
Read More

Minerva Issues Options

Author of the article: Published Jul 12, 2023  •  1 minute read Vancouver, British Columbia, July 12, 2023 (GLOBE NEWSWIRE) — Minerva Intelligence Inc. (TSXV: MVAI) (“Minerva” or the “Company”) announces the granting of incentive stock options to certain of its directors, officers and consultants to purchase up to an aggregate of 6,200,000 common shares in…
Fatal collision that killed 2 pilots brings a tragic end to the Reno air show and confounds experts
Read More

Fatal collision that killed 2 pilots brings a tragic end to the Reno air show and confounds experts

Author of the article: The Associated Press Scott Sonner Published Sep 22, 2023  •  Last updated 3 hours ago  •  4 minute read RENO, Nev. (AP) — The mid-air collision that killed two racing pilots in Reno last weekend is confounding aviation experts. The first- and second-place winning pilots, both Californians, crashed Sunday at the National…